Industry: Chemical & Material
Published Date: 2026-03-05
Pages: 110 Pages
Report ld: 6010354
Request Sample
Customized Report
Isoleucine (Ile) Market Size(US$)

CAGR 2026-2032
7.5%
Market Size,2032
USD 426
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Isoleucine (Ile) was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 426 million, growing at a CAGR of 7.5% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Isoleucine (Ile) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Isoleucine (Ile) is an essential branched-chain amino acid (BCAA), along with leucine and valine. It plays a vital role in muscle metabolism, endurance enhancement, tissue repair, and blood sugar regulation. As the human body cannot synthesize it naturally, Isoleucine (Ile) must be obtained through dietary sources or supplements.
Asia (particularly China, Japan, and South Korea), North America, and Europe are the key regional markets. China has become a vital production hub with a complete industrial chain and raw material advantages.
The global Isoleucine (Ile) market is steadily growing, driven by:
Rising demand for sports nutrition and functional foods (particularly among fitness enthusiasts and endurance athletes)
Increasing use in medical nutrition (especially for special medical foods for liver and metabolic diseases)
Growing demand in high-grade animal feed additives (especially for pigs and poultry)
Expanding applications in the biopharmaceutical sector, especially in recombinant protein production
Market Trends:
Rising Demand for Plant-based Isoleucine (Ile): Driven by veganism and sustainability trends.
Personalized Nutrition Growth: Increasing demand for customized formulas for elderly, diabetic patients, and athletes.
Technological Innovations: Bio-fermentation and green synthesis technologies enhance purity and production efficiency.
Cross-sector Applications Expansion: Isoleucine (Ile) usage is growing in biopolymers and novel functional materials beyond traditional sectors.
Competitive Landscape:
High Market Concentration: Dominated by a few large players from countries like China and Japan.
Cost Control as Key Factor: Raw material (glucose, nitrogen sources) and energy price fluctuations greatly impact producers.
Intensified Competition in Branding and Distribution: International markets demand quality certifications (ISO, HALAL, KOSHER) and stable supply chains.
Emerging Entrants Challenging Existing Order: Some new players from Europe, the US, and India are entering to disrupt the Asian monopoly.
Market Challenges:
Raw Material Price Volatility (corn, glucose) increases production cost uncertainties
Trade Barriers and Environmental Regulations intensify, especially anti-dumping cases against Chinese products in the US/EU
High Technical Barriers for Premium Applications, such as pharmaceutical-grade products requiring higher purity and safety standards
Overcapacity Risk: Especially in China, where excessive production expansion may lead to price wars
This report provides a comprehensive view of the global market for Isoleucine (Ile), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Isoleucine (Ile) market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Isoleucine (Ile).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Isoleucine (Ile) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Isoleucine (Ile) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Isoleucine (Ile) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Isoleucine (Ile) Product Introduction
1.2 Global Isoleucine (Ile) Market Size Forecast
1.2.1 Global Isoleucine (Ile) Sales Value (2021–2032)
1.2.2 Global Isoleucine (Ile) Sales Volume (2021–2032)
1.2.3 Global Isoleucine (Ile) Sales Price (2021–2032)
1.3 Isoleucine (Ile) Market Trends & Drivers
1.3.1 Isoleucine (Ile) Industry Trends
1.3.2 Isoleucine (Ile) Market Drivers & Opportunities
1.3.3 Isoleucine (Ile) Market Challenges
1.3.4 Isoleucine (Ile) Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Isoleucine (Ile) Players Revenue Ranking (2025)
2.2 Global Isoleucine (Ile) Revenue by Company (2021–2026)
2.3 Global Isoleucine (Ile) Sales Volume Ranking of Players (2025)
2.4 Global Isoleucine (Ile) Sales Volume by Company (2021–2026)
2.5 Global Isoleucine (Ile) Average Price by Company (2021–2026)
2.6 Key Manufacturers Isoleucine (Ile) Manufacturing Base and Headquarters
2.7 Key Manufacturers Isoleucine (Ile) Product Offerings
2.8 Key Manufacturers Start of Mass Production of Isoleucine (Ile)
2.9 Isoleucine (Ile) Market Competitive Analysis
2.9.1 Isoleucine (Ile) Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Isoleucine (Ile) Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Isoleucine (Ile) revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Isoleucine (Ile) Market Classification
3.1 Introduction by Type
3.1.1 Food Grade
3.1.2 Pharmaceutical Grade
3.1.3 Feed Grade
3.1.4 Global Isoleucine (Ile) Sales Value by Type
3.1.4.1 Global Isoleucine (Ile) Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Isoleucine (Ile) Sales Value, by Type (2021–2032)
3.1.4.3 Global Isoleucine (Ile) Sales Value, by Type (%), 2021–2032
3.1.5 Global Isoleucine (Ile) Sales Volume by Type
3.1.5.1 Global Isoleucine (Ile) Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Isoleucine (Ile) Sales Volume, by Type (2021–2032)
3.1.5.3 Global Isoleucine (Ile) Sales Volume, by Type (%), 2021–2032
3.1.6 Global Isoleucine (Ile) Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Sports Nutrition
4.1.3 Food & Beverages
4.1.4 Animal Nutrition
4.1.5 Others
4.2 Global Isoleucine (Ile) Sales Value by Application
4.2.1 Global Isoleucine (Ile) Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Isoleucine (Ile) Sales Value, by Application (2021–2032)
4.2.3 Global Isoleucine (Ile) Sales Value, by Application (%), 2021–2032
4.3 Global Isoleucine (Ile) Sales Volume by Application
4.3.1 Global Isoleucine (Ile) Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Isoleucine (Ile) Sales Volume, by Application (2021–2032)
4.3.3 Global Isoleucine (Ile) Sales Volume, by Application (%), 2021–2032
4.4 Global Isoleucine (Ile) Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Isoleucine (Ile) Sales Value by Region
5.1.1 Global Isoleucine (Ile) Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Isoleucine (Ile) Sales Value by Region (2021–2026)
5.1.3 Global Isoleucine (Ile) Sales Value by Region (2027–2032)
5.1.4 Global Isoleucine (Ile) Sales Value by Region (%), 2021–2032
5.2 Global Isoleucine (Ile) Sales Volume by Region
5.2.1 Global Isoleucine (Ile) Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Isoleucine (Ile) Sales Volume by Region (2021–2026)
5.2.3 Global Isoleucine (Ile) Sales Volume by Region (2027–2032)
5.2.4 Global Isoleucine (Ile) Sales Volume by Region (%), 2021–2032
5.3 Global Isoleucine (Ile) Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Isoleucine (Ile) Sales Value, 2021–2032
5.4.2 North America Isoleucine (Ile) Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Isoleucine (Ile) Sales Value, 2021–2032
5.5.2 Europe Isoleucine (Ile) Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Isoleucine (Ile) Sales Value, 2021–2032
5.6.2 Asia Pacific Isoleucine (Ile) Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Isoleucine (Ile) Sales Value, 2021–2032
5.7.2 South America Isoleucine (Ile) Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Isoleucine (Ile) Sales Value, 2021–2032
5.8.2 Middle East & Africa Isoleucine (Ile) Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Isoleucine (Ile) Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Isoleucine (Ile) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Isoleucine (Ile) Sales Value, 2021–2032
6.2.2 Key Countries/Regions Isoleucine (Ile) Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Isoleucine (Ile) Sales Value, 2021–2032
6.3.2 United States Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Isoleucine (Ile) Sales Value, 2021–2032
6.4.2 Europe Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Isoleucine (Ile) Sales Value, 2021–2032
6.5.2 China Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.5.3 China Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Isoleucine (Ile) Sales Value, 2021–2032
6.6.2 Japan Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Isoleucine (Ile) Sales Value, 2021–2032
6.7.2 South Korea Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Isoleucine (Ile) Sales Value, 2021–2032
6.8.2 Southeast Asia Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Isoleucine (Ile) Sales Value, 2021–2032
6.9.2 India Isoleucine (Ile) Sales Value by Type (%), 2025 vs 2032
6.9.3 India Isoleucine (Ile) Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Ajinomoto
7.1.1 Ajinomoto Company Information
7.1.2 Ajinomoto Introduction and Business Overview
7.1.3 Ajinomoto Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Ajinomoto Isoleucine (Ile) Product Offerings
7.1.5 Ajinomoto Recent Developments
7.2 Kyowa Hakko
7.2.1 Kyowa Hakko Company Information
7.2.2 Kyowa Hakko Introduction and Business Overview
7.2.3 Kyowa Hakko Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Kyowa Hakko Isoleucine (Ile) Product Offerings
7.2.5 Kyowa Hakko Recent Developments
7.3 Amino GmbH
7.3.1 Amino GmbH Company Information
7.3.2 Amino GmbH Introduction and Business Overview
7.3.3 Amino GmbH Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Amino GmbH Isoleucine (Ile) Product Offerings
7.3.5 Amino GmbH Recent Developments
7.4 Fufeng Group
7.4.1 Fufeng Group Company Information
7.4.2 Fufeng Group Introduction and Business Overview
7.4.3 Fufeng Group Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Fufeng Group Isoleucine (Ile) Product Offerings
7.4.5 Fufeng Group Recent Developments
7.5 Yichang SanXia Proudin Biopharmaceutical
7.5.1 Yichang SanXia Proudin Biopharmaceutical Company Information
7.5.2 Yichang SanXia Proudin Biopharmaceutical Introduction and Business Overview
7.5.3 Yichang SanXia Proudin Biopharmaceutical Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Yichang SanXia Proudin Biopharmaceutical Isoleucine (Ile) Product Offerings
7.5.5 Yichang SanXia Proudin Biopharmaceutical Recent Developments
7.6 Wuxi Jinghai Amino Acid
7.6.1 Wuxi Jinghai Amino Acid Company Information
7.6.2 Wuxi Jinghai Amino Acid Introduction and Business Overview
7.6.3 Wuxi Jinghai Amino Acid Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Wuxi Jinghai Amino Acid Isoleucine (Ile) Product Offerings
7.6.5 Wuxi Jinghai Amino Acid Recent Developments
7.7 Meihua Group
7.7.1 Meihua Group Company Information
7.7.2 Meihua Group Introduction and Business Overview
7.7.3 Meihua Group Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Meihua Group Isoleucine (Ile) Product Offerings
7.7.5 Meihua Group Recent Developments
7.8 Jiahe Biological Technology
7.8.1 Jiahe Biological Technology Company Information
7.8.2 Jiahe Biological Technology Introduction and Business Overview
7.8.3 Jiahe Biological Technology Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Jiahe Biological Technology Isoleucine (Ile) Product Offerings
7.8.5 Jiahe Biological Technology Recent Developments
7.9 Hubei Bafeng Pharmaceutical
7.9.1 Hubei Bafeng Pharmaceutical Company Information
7.9.2 Hubei Bafeng Pharmaceutical Introduction and Business Overview
7.9.3 Hubei Bafeng Pharmaceutical Isoleucine (Ile) Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Hubei Bafeng Pharmaceutical Isoleucine (Ile) Product Offerings
7.9.5 Hubei Bafeng Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Isoleucine (Ile) Industrial Chain
8.2 Isoleucine (Ile) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Isoleucine (Ile) Sales Model
8.5.2 Sales Channels
8.5.3 Isoleucine (Ile) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Isoleucine (Ile) market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 426 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
The global Isoleucine (Ile) market is projected to grow from US$ 259 million in 2025 to US$ 426 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 140
USD 4900.00
(Single User License)
The global Isoleucine (Ile) market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 426 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 128
USD 2900.00
(Single User License)
The global Isoleucine (Ile) market is projected to grow from US$ 236 million in 2024 to US$ 399 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 144
USD 4900.00
(Single User License)
The global market for Isoleucine (Ile) was estimated to be worth US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 104
USD 3950.00
(Single User License)
The global Isoleucine (Ile) market is projected to grow from US$ 259 million in 2025 to US$ 399 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published Date: 2025-06-22
Pages: 134
USD 4900.00
(Single User License)
The global Isoleucine (Ile) market size was US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 76
USD 4250.00
(Single User License)
The global market for Isoleucine (Ile) was valued at US$ 236 million in the year 2024 and is projected to reach a revised size of US$ 399 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-06-22
Pages: 93
USD 2900.00
(Single User License)
The global market for Isoleucine (Ile) was estimated to be worth US$ 235 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 3950.00
(Single User License)
Isoleucine is one of nine essential amino acids in humans (present in dietary proteins), Isoleucine has diverse physiological functions, such as assisting wound healing, detoxification of nitrogenous wastes, stimulating immune function, and promoting secretion of several hormones.
Published Date: 2024-04-25
Pages: 113
USD 4900.00
(Single User License)
The global Isoleucine (Ile) market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 426 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
The global Isoleucine (Ile) market is projected to grow from US$ 259 million in 2025 to US$ 426 million by 2032, at a CAGR of 7.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 140
The global Isoleucine (Ile) market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 426 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 128
The global Isoleucine (Ile) market is projected to grow from US$ 236 million in 2024 to US$ 399 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 144
The global market for Isoleucine (Ile) was estimated to be worth US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 104
The global Isoleucine (Ile) market is projected to grow from US$ 259 million in 2025 to US$ 399 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2025-06-22
Pages: 134
The global Isoleucine (Ile) market size was US$ 236 million in 2024 and is forecast to a readjusted size of US$ 399 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 76
The global market for Isoleucine (Ile) was valued at US$ 236 million in the year 2024 and is projected to reach a revised size of US$ 399 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-06-22
Pages: 93
The global market for Isoleucine (Ile) was estimated to be worth US$ 235 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
Isoleucine is one of nine essential amino acids in humans (present in dietary proteins), Isoleucine has diverse physiological functions, such as assisting wound healing, detoxification of nitrogenous wastes, stimulating immune function, and promoting secretion of several hormones.
Published: 2024-04-25
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now